Mycoplasma Testing Market Overview
The Global Mycoplasma Testing Market is anticipated to have held a market value of USD 514 million in the year 2017 and is expected to grow at a CAGR of 11.6% during the forecast period. Mycoplasma testing used to detect contamination in given biologic sample.
The factors such as Increasing R&D expense and new product launches are expected to propel the growth of the market. However, available of alternative traditional method hamper the market growth over the forecast period.
Intended Audience:
- Mycoplasma testing products Manufacturers and vendors
- Mycoplasma testing service providers
- Pharmaceutical and Biotech companies
- Contract research organization
- Various research and consulting firms
Free Sample Copy at https://www.marketresearchfuture.com/sample_request/6776
Increasing R&D investment and new product launches are expected to drive the growth of market. According to the Center for Drug Evaluation and Research, in 2017, about 46 novel drug approvals were the 22 novel drug approval in 2016. On other hand, the available of alternative traditional method can restrain the market growth over the assessment period.
Mycoplasma Testing Market Key Players:
Some of the prominent players in the global mycoplasma testing market are
- Charles River Laboratories Inc.
- Merck KGaA
- Lonza Group Ltd
- Roche Diagnostics
- SGS S.A.
- American Type Culture Collection
- Invivogen
- Wuxi Apptec
- Promocell GmbH
- and Thermo Fisher Scientific Inc
Mycoplasma Testing Market Segmentation:
The global mycoplasma testing market has been segmented into product, Technique, application, and end user.
Based on product, market is segmented into kits & reagents, instruments, and services. The kits & reagents segment is expected to account for the largest share and fastest growing segment of the global market in 2017.
Based on technique, market is segmented into Enzyme-based, PCR, ELISA, Direct Assay, Indirect Assay, Others.
Based on application, has been segmented into cell line and cell therapy testing, virus testing, row material testing, lot release testing, and others.
Based on end user, has been segmented into pharmaceutical and biological manufacturing, contract research organizations, cell banks, and others
Mycoplasma Testing Market Regional Analysis:
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
Geographically, the Americas is expected to dominate the global market owing to the presence of well-established players and growth in pharmaceutical and medical device companies. Europe is expected to hold the second largest position in the global market. Asia-Pacific is expected to be the fastest growing market owing to the increasing adoption of the technologies. Furthermore, the Middle East and Africa region is expected to account for the least market share in the global market.
Browse Complete Premium Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/mycoplasma-testing-market-6776
Global Mycoplasma Testing Market, by Region
- Americas
- North America
- US
- Canada
- South America
- North America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Western Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
About Market Research Future: Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
+1 646 845 9312
Comments
Post a Comment